BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$661M |
| 2 |
Invesco QQQ Trust
QQQ
|
$506M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$504M |
| 4 |
DuPont de Nemours
DD
|
$350M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$333M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$356M |
| 2 |
Linde
LIN
|
$339M |
| 3 |
Visa
V
|
$276M |
| 4 |
Apple
AAPL
|
$207M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$184M |
Sector Composition
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.42% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Financials | 8.42% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Marsh & McLennan
MMC
$101B
| $94.3M | 0.13% | 566,302 +136,302 | +32% | +$22.7M |
|
102
Lam Research
LRCX
$127B
| $94.2M | 0.13% | 177,763 +81,262 | +84% | +$43.1M |
|
103
Morgan Stanley
MS
$240B
| $92.8M | 0.13% | 1,056,851 -896,669 | -46% | -$78.7M |
|
104
Gilead Sciences
GILD
$140B
| $92.1M | 0.13% | 1,110,326 -182,332 | -14% | -$15.1M |
|
105
Regeneron Pharmaceuticals
REGN
$61.5B
| $90.4M | 0.13% | 110,038 +9,640 | +10% | +$7.92M |
|
106
Norfolk Southern
NSC
$62.8B
| $90.3M | 0.13% | 426,111 +110,180 | +35% | +$23.4M |
|
107
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $90.2M | 0.13% | 2,057,536 +1,679,312 | +444% | +$73.7M |
|
108
Keysight
KEYS
$28.1B
| $89.5M | 0.13% | 554,465 +242,524 | +78% | +$39.2M |
|
109
United Parcel Service
UPS
$74.1B
| $89.4M | 0.13% | 460,799 -154,643 | -25% | -$30M |
|
110
Vertex Pharmaceuticals
VRTX
$100B
| $87.9M | 0.12% | 279,084 +30,763 | +12% | +$9.69M |
|
111
Walmart
WMT
$774B
| $87.4M | 0.12% | 592,928 -372,156 | -39% | -$54.9M |
|
112
Progressive
PGR
$145B
| $86.5M | 0.12% | 604,644 +64,717 | +12% | +$9.26M |
|
113
Cadence Design Systems
CDNS
$95.5B
| $85.6M | 0.12% | 407,611 +170,574 | +72% | +$35.8M |
|
114
Centene
CNC
$14.3B
| $84.4M | 0.12% | 1,335,272 +873,729 | +189% | +$55.2M |
|
115
Elevance Health
ELV
$71.8B
| $84.1M | 0.12% | 182,951 +103,542 | +130% | +$47.6M |
|
116
Microchip Technology
MCHP
$35.1B
| $83.1M | 0.12% | 991,555 +436,414 | +79% | +$36.6M |
|
117
Enterprise Products Partners
EPD
$69.6B
| $82.5M | 0.12% | 3,184,365 -668,165 | -17% | -$17.3M |
|
118
SPDR S&P Biotech ETF
XBI
$5.07B
| $81.8M | 0.11% | 1,073,535 +583,998 | +119% | +$44.5M |
|
119
KLA
KLAC
$115B
| $81M | 0.11% | 202,927 +68,383 | +51% | +$27.3M |
|
120
American Express
AXP
$231B
| $80.4M | 0.11% | 487,523 +56,166 | +13% | +$9.26M |
|
121
Moderna
MRNA
$9.37B
| $79.7M | 0.11% | 519,071 -42,395 | -8% | -$6.51M |
|
122
NextEra Energy, Inc.
NEE
$148B
| $79.7M | 0.11% | 1,033,757 -221,304 | -18% | -$17.1M |
|
123
General Mills
GIS
$26.4B
| $79.3M | 0.11% | 927,449 -13,711 | -1% | -$1.17M |
|
124
Mondelez International
MDLZ
$79.5B
| $78.9M | 0.11% | 1,131,431 -643,646 | -36% | -$44.9M |
|
125
Intuitive Surgical
ISRG
$170B
| $78.6M | 0.11% | 307,620 +191,768 | +166% | +$49M |
|